Bath & Body Works (NYSE:BBWI - Get Free Report) had its price target dropped by analysts at JPMorgan Chase & Co. from $24.00 to $23.00 in a research report issued on Friday, Benzinga reports. The firm presently has a "neutral" rating on the stock. JPMorgan Chase & Co.'s target price suggests a potential upside of 22.16% from the company's previous close.
Several other research firms have also recently weighed in on BBWI. Barclays cut their price objective on Bath & Body Works from $23.00 to $22.00 and set an "equal weight" rating for the company in a research report on Thursday, August 27th. UBS Group raised their price target on shares of Bath & Body Works from $17.00 to $22.00 and gave the stock a "neutral" rating in a research report on Friday, November 13th. Bank of America set a $25.00 price objective on shares of Bath & Body Works and gave the stock a "buy" rating in a report on Friday. Wells Fargo & Company reduced their target price on shares of Bath & Body Works from $25.00 to $24.00 and set an "overweight" rating for the company in a research note on Friday. Finally, Jefferies Financial Group restated a "hold" rating and set a $21.00 price objective on shares of Bath & Body Works in a research report on Thursday. Four investment analysts have rated the stock with a Buy rating, fifteen have issued a Hold rating and one has given a Sell rating to the company's stock. According to MarketBeat, the company presently has a consensus rating of "Hold" and an average price target of $22.20.
Read Our Latest Research Report on BBWI
Bath & Body Works Stock Performance
Shares of Bath & Body Works stock traded down $0.08 during midday trading on Friday, reaching $18.83. 2,793,431 shares of the company's stock traded hands, compared to its average volume of 6,028,515. Bath & Body Works has a 52 week low of $14.27 and a 52 week high of $24.94. The company's 50 day simple moving average is $19.24 and its 200 day simple moving average is $19.77. The company has a market cap of $3.80 billion, a price-to-earnings ratio of 4.91, a price-to-earnings-growth ratio of 0.93 and a beta of 1.31.
Bath & Body Works (NYSE:BBWI - Get Free Report) last issued its quarterly earnings data on Thursday, November 19th. The company reported $0.26 earnings per share for the quarter, beating analysts' consensus estimates of $0.12 by $0.14. Bath & Body Works had a negative return on equity of 53.48% and a net margin of 10.83%. The business had revenue of $1.58 billion for the quarter, compared to the consensus estimate of $1.55 billion. During the same period last year, the business earned $0.37 EPS. The firm's revenue was down 1.1% compared to the same quarter last year. Bath & Body Works has set its Q4 2026 guidance at 1.410-1.610 EPS and its FY 2026 guidance at 2.600-2.800 EPS. As a group, equities research analysts predict that Bath & Body Works will post 2.74 earnings per share for the current year.
Hedge Funds Weigh In On Bath & Body Works
Hedge funds have recently added to or reduced their stakes in the company. Allworth Financial LP grew its holdings in Bath & Body Works by 3.1% during the 3rd quarter. Allworth Financial LP now owns 17,371 shares of the company's stock worth $277,000 after acquiring an additional 521 shares during the period. Pathstone Holdings LLC increased its stake in Bath & Body Works by 1.1% in the third quarter. Pathstone Holdings LLC now owns 52,031 shares of the company's stock valued at $828,000 after purchasing an additional 581 shares in the last quarter. Parallel Advisors LLC grew its holdings in shares of Bath & Body Works by 35.5% in the 1st quarter. Parallel Advisors LLC now owns 2,570 shares of the company's stock valued at $48,000 after buying an additional 673 shares during the period. Rothschild Investment LLC lifted its holdings in Bath & Body Works by 12.5% during the third quarter. Rothschild Investment LLC now owns 7,570 shares of the company's stock worth $121,000 after acquiring an additional 841 shares in the last quarter. Finally, GAMMA Investing LLC grew its stake in Bath & Body Works by 40.7% in the second quarter. GAMMA Investing LLC now owns 5,050 shares of the company's stock valued at $117,000 after acquiring an additional 1,460 shares during the period. Institutional investors own 95.14% of the company's stock.
Trending Headlines about Bath & Body Works
Here are a few of the latest headlines about BBWI:
- Positive Sentiment: BBWI announced a new $500 million share-repurchase program and says its Fuel for Growth initiative is expected to generate $200 million in cost savings, potentially supporting earnings and shareholder returns. Long-term investor takeaways
- Neutral Sentiment: Wells Fargo, Morgan Stanley and Baird each lowered their price targets, but retained their respective Overweight, Equal Weight and Neutral ratings. Their revised targets remain above the recent share price, indicating mixed views rather than a broad downgrade. Wells Fargo rating
- Neutral Sentiment: A limited-edition holiday fragrance collection with Pantone adds a new seasonal offering, though the financial impact is not yet clear. Pantone collaboration announcement
About Bath & Body Works
(
Get Free Report)
Bath & Body Works, Inc. is a specialty retailer focused on personal care and home fragrance products. Its offerings include body lotions, soaps, fragrances, hand sanitizers, candles and other home-fragrance items, sold under the Bath & Body Works and White Barn brands. The company serves customers through its stores and e-commerce platform in the United States and Canada, as well as through international franchise, license and wholesale partners. Bath & Body Works traces its roots to a store launched in 1990.
See Also

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Bath & Body Works, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Bath & Body Works wasn't on the list.
While Bath & Body Works currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
AI spending is reshaping the market, and the opportunity extends far beyond the biggest chipmakers. Discover 10 stocks set to benefit from powerful trends in AI infrastructure, cloud computing, energy, capital returns, and consumer growth this fall.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.
Link copied to clipboard.